Health Care/Hospital

Gracell Biotechnologies to Participate in BTIG 2022 Biotechnology Conference

SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, July 26, 2022 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell"), a global clinical-stage biopharmaceutical company dedicated to discovering and developing highly efficacious and affordable cell therapies for the treatment o...

2022-07-26 20:30 1709

Motex Showcases Award-Winning Face Masks in Miami at FIME 2022

CHANGHUA, Taiwan, July 26, 2022 /PRNewswire/ -- Motex Healthcare Corp. , the world's largest medical grade mask producer and certified by the Guinness World Records, is featuring their latest award-winning face masks at this ...

2022-07-26 20:00 1669

Novavax Nuvaxovid™ COVID-19 Vaccine Granted Provisional Registration in Australia for Use in Adolescents Aged 12 Through 17

* Nuvaxovid™ is the first protein-based COVID-19 vaccine available for use in adolescents aged 12 through 17 inAustralia GAITHERSBURG, Md., July 26, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines fo...

2022-07-26 20:00 1913

Nuance Pharma announces the completion of dosing for all NTM-001 Phase 1 clinical study participants in HKU Clinical Trials Centre

* All 16 healthy normal volunteers (HNVs) were dosed and no serious adverse event was reported * The NTM-001 Phase I clinical study is expected to be completed by the end of 2022 SHANGHAI, July 26, 2022 /PRNewswire/ -- Nuance Pharma ("the Company") announces the completion of dosing for all H...

2022-07-26 17:04 2076

Otsuka Pharmaceuticals Implements Antibody Discovery, and Cell & Gene Therapy Research & Development by Utilizing the Berkeley Lights Beacon® Platform

EMERYVILLE, Calif., July 26, 2022 /PRNewswire/ -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced Otsuka Pharmaceuticals, a leading pharmaceutical company, has implemented the use of the Berkeley Lights Beacon® system for antibody discovery, as well as cell ...

2022-07-26 11:43 1900

Ascentage Pharma and Tanner Pharma Group Initiate a Global Innovative Named Patient Program

SUZHOU, China and ROCKVILLE, Md. and CHARLOTTE, N.C., July 25, 2022 /PRNewswire/ --Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, andTanner Ph...

2022-07-25 21:59 2328

Anti-PD-1 monoclonal antibody Puyouheng™ (HX-008, Pucotenlimab injection) Co-developed by LEPU BIOPHARMA and HANX BIOPHARMACEUTICALS was approved for marketing in China by NMPA

HANGZHOU, China, July 25, 2022 /PRNewswire/ -- Anti-PD-1 monoclonal antibody – PuyouhengTM (HX-008, pucotenlimab injection), was conditionally approved by the National Medical Products Administration (NMPA) for marketing inChina to treat patients with unresectable or metastatic microsatellite ins...

2022-07-25 18:47 1979

Fuzhou Rides on the Opportunity of "Digital China" to Make Its Name in the World

FUZHOU, China, July 25, 2022 /PRNewswire/ -- "Discover Fuzhou: The Digital China Summit", the themed promo film ofFuzhou City, Fujian Province, was shown on "China screen" at Times Square, New York on July 22. Riding on the opportunity of "Digital China",Fuzhou, a coastal city, is presenting its ...

2022-07-25 15:21 2149

Qiming's Portfolio Company InventisBio Lists on STAR Market

SHANGHAI, July 24, 2022 /PRNewswire/ -- Qiming Venture Partners' portfolio company InventisBio (SHSE: 688382), a leading company in innovative drug development, today listed on the Science and Technology Innovation Board (the "STAR Market") of the Shanghai Stock Exchange.The issue price is CNY 18...

2022-07-25 11:55 2767

4DMedical Lauds U.S. House of Representatives for Including Burn Pit Population Surveillance in FY 2023 Appropriations

Thousands of Impacted Veterans Will Benefit from Congressional Efforts LOS ANGELES, July 23, 2022 /PRNewswire/ -- 4DMedical, the leading developer of functional imaging software for respiratory illness, today praised the U.S. House of Representatives for including language calling on the Departme...

2022-07-23 00:59 4772

Nisun International Cooperates with Pinhutang Distillery to Facilitate Agricultural Product Purchases

SHANGHAI, July 22, 2022 /PRNewswire/ -- Nisun International Enterprise Development Group Co., Ltd ("Nisun" or the "Company") (Nasdaq: NISN), a provider of innovative comprehensive solutions through an integration of technology, industry, and finance, announced Fanlunke Supply Chain Management ( S...

2022-07-22 20:00 3073

Alterity Therapeutics: Appendix 4C - Q4 FY22 Quarterly Cash Flow Report

* Phase 2 clinical trial for ATH434 commences in New Zealand and patient enrolment begins * Regulatory approval from the U.K. and Italian regulatory agencies to proceed with the Phase 2 trial * A$4.1 million R&D Tax Incentive Scheme refund * Cash balance on 30 June 2022 of A$34.8M MELBOURN...

2022-07-22 19:25 1646

TIANGEN to Participate in the 2022 AACC Meeting

CHICAGO, July 21, 2022 /PRNewswire/ -- TIANGEN, a leading brand in the field of nucleic acid purification inChina, has announced its participation in the 2022 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo fromJuly 26 to 28 in Chicago where it wil...

2022-07-22 10:15 1893

Ascentage Pharma Announces Clinical Trial Application for Olverembatinib (HQP1351) Approved in Canada

SUZHOU, China and ROCKVILLE, MD, July 21, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Phase Ib study of Ascentage Pharma's novel...

2022-07-22 07:59 2252

uLab™ clear aligner platform is now available in Australia and New Zealand

MEMPHIS, Tenn., July 22, 2022 /PRNewswire/ -- uLab Systems™, the creator of the uSmile™ clear aligner system and the uDesign® treatment planning software, announces the clearance of the uLab product suite from the Therapeutic Goods Administration (TGA) and Medsafe, the regulatory authorities for ...

2022-07-22 05:04 2250

AI-based Cancer Solution Pioneer Lunit Makes Market Debut

SEOUL, South Korea, July 21, 2022 /PRNewswire/ -- Lunit, a global provider of AI-powered cancer solutions, announced today that it made its stock market debut on the South Korean KOSDAQ under the ticker "A32813". Lunit's initial public offering of 1,215,800 shares of its common stock was priced a...

2022-07-21 21:00 1647

Waterdrop Launches Industry's First Customized Critical Illness Insurance Product with Waiver on Health Declarations

BEIJING, July 21, 2022 /PRNewswire/ -- Waterdrop Inc. ("Waterdrop", the "Company" or "we") (NYSE: WDH), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it has partnered with China United Property Insurance Company Lim...

2022-07-21 18:00 2770

ImmVira's intravenous administered oHSV MVR-T3011 IV demonstrated promising clinical biological activities

SHENZHEN, China, July 20, 2022 /PRNewswire/ -- ImmVira's global first intravenous ("IV") administered oncolytic herpes simplex virus ("oHSV") product MVR-T3011 IV has completed the first three cohort escalation in the U.S. Phase I clinical trial, tested dosage from 1x106 to 1x108 PFU on 10 subjec...

2022-07-21 08:00 1610

Recruitment complete for Clarity's PROPELLER prostate cancer diagnostic trial

SYDNEY, July 20, 2022 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, is pleased to announce the completion of recruitment for the Phase I PROPELLER diagnosti...

2022-07-20 21:06 1384

Daewoong Pharmaceutical Gets First Korean US FDA Fast-Track for New Idiopathic Pulmonary Fibrosis Drug

* US Food and Drug Administration (FDA) fast-tracks idiopathic pulmonary fibrosis treatment DWN12088 * First-in-class new drug to quickly take on the pulmonary fibrosis market, predicted to reach$6.1 billion globally by 2030 SEOUL, South Korea, July 20, 2022 /PRNewswire/ -- As many Korean p...

2022-07-20 21:00 1467
1 ... 147148149150151152153 ... 278